SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-24-000009
Filing Date
2024-02-21
Accepted
2024-02-20 18:14:07
Documents
14
Period of Report
2024-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K supn-20240214.htm   iXBRL 8-K 25073
  Complete submission text file 0001356576-24-000009.txt   150017

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20240214.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20240214_lab.xml EX-101.LAB 24138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20240214_pre.xml EX-101.PRE 12522
16 EXTRACTED XBRL INSTANCE DOCUMENT supn-20240214_htm.xml XML 2727
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 24655498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)